CJC 1295 With/No DAC Pre-mixed Pen 2mg

£80.00

CJC-1295 Growth Hormone-Releasing Hormone (GHRH) Analog

CJC-1295 is a synthetic 30-amino acid peptide analog of Growth Hormone-Releasing Hormone (GHRH). It exists in two common research forms:

CJC-1295 with DAC (Drug Affinity Complex)

  • Modification: Attached to a Drug Affinity Complex (DAC) for extended half-life

  • Half-life: Approximately 6–8 days

  • Mechanism: Provides sustained, prolonged elevation of GH and IGF-1 levels through less frequent dosing

CJC-1295 without DAC (also known as Mod GRF 1-29)

  • Modification: No DAC attachment (short-acting version)

  • Half-life: Approximately 30 minutes

  • Mechanism: Mimics natural GHRH pulses, producing sharp, physiologic GH release when combined with a GHRP (such as Ipamorelin)

Key Research Applications (Both Forms):

  • Stimulation of endogenous growth hormone secretion

  • Increase in circulating IGF-1 levels

  • Muscle growth, recovery, and body composition studies

  • Fat metabolism and lipolysis research

  • Anti-aging and regenerative protocols

  • Sleep quality and recovery optimization

Common Research Use: CJC-1295 with DAC is typically studied for steady-state GH elevation, while CJC-1295 No DAC (Mod GRF 1-29) is preferred for creating multiple daily GH pulses, especially when stacked with Ipamorelin.

For laboratory research use only. Not intended for human or veterinary use.

Varient:

CJC-1295 Growth Hormone-Releasing Hormone (GHRH) Analog

CJC-1295 is a synthetic 30-amino acid peptide analog of Growth Hormone-Releasing Hormone (GHRH). It exists in two common research forms:

CJC-1295 with DAC (Drug Affinity Complex)

  • Modification: Attached to a Drug Affinity Complex (DAC) for extended half-life

  • Half-life: Approximately 6–8 days

  • Mechanism: Provides sustained, prolonged elevation of GH and IGF-1 levels through less frequent dosing

CJC-1295 without DAC (also known as Mod GRF 1-29)

  • Modification: No DAC attachment (short-acting version)

  • Half-life: Approximately 30 minutes

  • Mechanism: Mimics natural GHRH pulses, producing sharp, physiologic GH release when combined with a GHRP (such as Ipamorelin)

Key Research Applications (Both Forms):

  • Stimulation of endogenous growth hormone secretion

  • Increase in circulating IGF-1 levels

  • Muscle growth, recovery, and body composition studies

  • Fat metabolism and lipolysis research

  • Anti-aging and regenerative protocols

  • Sleep quality and recovery optimization

Common Research Use: CJC-1295 with DAC is typically studied for steady-state GH elevation, while CJC-1295 No DAC (Mod GRF 1-29) is preferred for creating multiple daily GH pulses, especially when stacked with Ipamorelin.

For laboratory research use only. Not intended for human or veterinary use.